July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Naveen Pemmaraju: Proud to be one of the featured lead authors for one of the five selected abstracts for the Plenary Session at ASCO
Jun 10, 2025, 04:55

Naveen Pemmaraju: Proud to be one of the featured lead authors for one of the five selected abstracts for the Plenary Session at ASCO

Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center, shared a post on LinkedIn:

“Proud to be one of the featured lead authors for one of the five selected abstracts for the Plenary Session at American Society of Clinical Oncology (ASCO) | Dr Andrew Kuykendall presented on behalf of our group , the VERIFY program, a positive randomized Ph3 study of Rusfertide, first-in-class hepcidin mimetic for patients with phlebotomy-dependent Polycythemia Vera (PV).”

Naveen Pemmaraju

More posts featuring Naveen Pemmaraju.